Molecule News and Research

RSS

Study exploits biomolecular condensates to inhibit androgen receptor in prostate cancer

Transcription factors play essential roles in turning the genetic information encoded in genes into proteins in all cells and organisms.

5 Dec 2023

Study uses game theory to show low tumor heterogeneity leads to higher aggression

A study by the University of the Basque Country (UPV/EHU) uses game theory to establish that tumors with less cellular heterogeneity are more aggressive.

5 Dec 2023

Investigating IDO1 and PDL1: Key immune checkpoints in cutaneous leishmaniasis research

In this Interview News Med talks to Dr. Nidhi Dey about immune checkpoints IDO1 and PDL1 and how they relate to cutaneous leishmaniasis research.

From TissueGnostics 5 Dec 2023

Scientists unmask molecule that fuels leukemia growth

In a study published in the journal Genes & Diseases, researchers from Beckman Research Institute of City of Hope, explored the impact of m6A modification on the maturation process of precursor microRNAs (pre-miRNAs) and its potential role in tumorigenesis.

4 Dec 2023

MU researchers unveil the immune system's secret weapon against lung cancer

As one of the most insidious diseases in the world, cancer has few treatments that work to eradicate it completely.

4 Dec 2023

UCLA studies unravel metabolic pathways in prostate cancer treatment

Two new studies led by researchers from the UCLA Jonsson Comprehensive Cancer Center give insight into how cells use energy to influence the way prostate tumors survive and grow - advancements that can help explain why some prostate cancers become resistant to hormone therapy, the most commonly used treatment for men with advanced stages of the disease.

4 Dec 2023

CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing

CN Bio today announced its PhysioMimix® assay for Non-alcoholic steatohepatitis (NASH).

From CN Bio 4 Dec 2023

Navigating STXBP1-related disorders: Unraveling clinical and developmental outcomes

Researchers examined the combined patient-years of seizure and developmental histories in individuals with disorders related to the STXBP1 gene.

4 Dec 2023

Gut microbe Lactobacillus found to bolster stress resilience, new study reveals

Study demonstrates that the gut microbe Lactobacillus helps maintain normal levels of the cytokine interferon-gamma (IFNγ), providing protection against stress-induced disruptions in a mouse model. The findings suggest Lactobacillus's crucial role in building resilience to environmental stressors, highlighting its potential in treating mood disorders.

3 Dec 2023

ADA Forsyth scientists test novel technology to treat endodontic diseases more effectively

Want to avoid a root canal? In the future, you might be able to opt for tissue regeneration instead. ADA Forsyth scientists are testing a novel technology to treat endodontic diseases (diseases of the soft tissue or pulp in your teeth) more effectively.

1 Dec 2023

Canadian researchers aim to reduce chronic inflammation and comorbidities in HIV patients

To mark the occasion of World AIDS Day, find out how Dr. Madeleine Durand and Andrés Finzi are working to reduce chronic inflammation and the risk of comorbidities in people living with HIV.

30 Nov 2023

Scientists uncover cellular cause of heart defects in babies born to women with diabetes

When women with diabetes become pregnant, they face not only the typical challenges of pregnancy and impending parenthood, but also a scary statistic: they're five times more likely to have a baby with a congenital heart defect.

30 Nov 2023

The effects of vitamin K on bone health

Existing scientific data on the effects of vitamin K (VK) on bone health and elucidated the underlying mechanisms.

30 Nov 2023

C-Path's TRxA and Celdara Medical announce MOU to identify and advance promising new therapeutics

Critical Path Institute's (C-Path) Translational Therapeutics Accelerator (TRxA) and Celdara Medical today announced the signing of a Memorandum of Understanding (MOU) aimed at identifying and advancing promising new therapeutics in areas of high unmet medical need.

29 Nov 2023

Molecule News and Research

Study exploits biomolecular condensates to inhibit androgen receptor in prostate cancer

Study uses game theory to show low tumor heterogeneity leads to higher aggression

Investigating IDO1 and PDL1: Key immune checkpoints in cutaneous leishmaniasis research

Scientists unmask molecule that fuels leukemia growth

MU researchers unveil the immune system's secret weapon against lung cancer

UCLA studies unravel metabolic pathways in prostate cancer treatment

CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing

Navigating STXBP1-related disorders: Unraveling clinical and developmental outcomes

Gut microbe Lactobacillus found to bolster stress resilience, new study reveals

ADA Forsyth scientists test novel technology to treat endodontic diseases more effectively

Canadian researchers aim to reduce chronic inflammation and comorbidities in HIV patients

Scientists uncover cellular cause of heart defects in babies born to women with diabetes

The effects of vitamin K on bone health

C-Path's TRxA and Celdara Medical announce MOU to identify and advance promising new therapeutics

Collaborative study focuses on understanding the strength of adhesion of COVID-19 variants

Non-invasive monitoring of glucose and adenosine monophosphate biomarkers in saliva

AI predicts ideal sites for chemical alterations in drug molecules

Dissecting how co-transmission of interneurons helps in odor detection and discrimination

Researchers discover new gene targets for precision oncology in esophageal cancer

New cortex organoids more accurately represent the human brain

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News